Publication | Closed Access

Epirubicin and etoposide combination chemotherapy to treat hepatocellular carcinoma patients: a phase II study

OncologyHepatologyHepatocellular Carcinoma PatientsMedicineEtoposide Combination ChemotherapyPathologyPhase Ii StudyPharmacotherapyLiver CancerCancer TreatmentPharmacologyRadiation OncologyHepatocellular CarcinomaCancer Research